TVMR With the Innovalve System Trial - Pilot Study in Italy
← catalyst calendarSponsored by Edwards Lifesciences (industry) · EW — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
4actual
Sites
1
Country
Italy
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-01-24 | actual | When the study began enrolling |
| Primary completion | 2024-05-04 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2029-10-04 | estimated | The whole study's end, after follow-up |
| First posted | 2021-08-18 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-06-26 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Mitral Valve Regurgitation (Degenerative or Functional)
Intervention
- Device: Innovalve TMVR system
Primary outcome
what the primary-completion date above is the date OFAbsence of implant or delivery related serious adverse events at 30 days
measured 30 days
Permalink · EW's whole pipeline · Catalyst calendar · Every registered study · What changed